| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6243590 | European Journal of Radiology | 2013 | 7 Pages |
Abstract
Despite perfusion changes with both Perfusion CT and DCE-US in patients receiving treatment, only DCE-US at month 1 (with a decrease in the AUC of more than 40%) predicted non-progression at month 2 and may be a potential surrogate marker of tumor response during targeted therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Eric Frampas, Nathalie Lassau, Magaly Zappa, Marie-Pierre Vullierme, Serge Koscielny, Valérie Vilgrain,